The antimalarial drugs chloroquine and hydroxychloroquine have come to the public’s attention following recent comments by U.S. President Donald Trump about the new coronary pneumonia,media reported. In fact, who put the two drugs into a large-scale global trial. These may all be the reasons why the U.S. Food and Drug Administration approves the urgent use of hydroxychloroquine and chlorine in connection with neo-coronavirus treatment so quickly.
HHS said in a statement that the FDA allows these drugs to be donated to the National Strategic Reserve, which is then assigned by doctors, at their discretion, to hospitalized adolescents and adult seupas, but not for clinical trials, Politico reported. Sandoz is understood to have donated 30 million doses of hydroxychloroquine to the reserve agency, while Bayer has donated 1 million doses.
The FDA’s emergency authorization means more companies will be able to produce it or donate it. In addition to patients with neo-coronavirus, some chronic patients need hydroxychloroquine to treat their lupus and rheumatoid arthritis. Politico’s website notes that more and more patients are unable to dispense medicines because of a shortage of medicines, and there are reports that some doctors have been hoarding them for themselves.
Although scientific research to support chloroquine in the treatment of the new coronavirus has not yet emerged, studies from France and China have shown promising results. These initial studies were limited in scope, and at least one study in China showed that chloroquine therapy was no better than traditional therapies.
As always, it’s important to stress that people can’t prevent new coronavirus infectionby by taking drugs they might hear on TV. In Nigeria, someone tried to do so, and unfortunately, because overdosing on the drug took away his claim. Any chloroquine treatment should be performed by a health care provider in a hospital rather than at home.